First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
Asklepios BioPharmaceutical, Inc. (AskBio): First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...
Premature Death Risk's Surprising Early Warning Sign Revealed
The team reported that during the study period, 1,011 deaths occurred, meaning that the background rate of premature deaths was around one in seven people. However, the premature death rate appeared ...
Farmer's Weekly23h
Bacterial and fungal diseases of garlic
Garlic can be prone to bacterial and fungal diseases, and it’s important that farmers are proactive in preventing infection ...